Retmana IA - Search Results

1

Chromatographic bioanalytical assays for targeted covalent kinase inhibitors and their metabolites.

Retmana IA, Beijnen JH, Sparidans RW. Retmana IA, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jan 1;1162:122466. doi: 10.1016/j.jchromb.2020.122466. Epub 2020 Nov 30. J Chromatogr B Analyt Technol Biomed Life Sci. 2021. PMID: 33316750 Free article. Review.

2

Liquid chromatography-tandem mass spectrometric assay for the quantitative determination of the tyrosine kinase inhibitor quizartinib in mouse plasma using salting-out liquid-liquid extraction.

Retmana IA, Wang J, Schinkel AH, Schellens JHM, Beijnen JH, Sparidans RW. Retmana IA, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Sep 1;1061-1062:300-305. doi: 10.1016/j.jchromb.2017.07.034. Epub 2017 Jul 23. J Chromatogr B Analyt Technol Biomed Life Sci. 2017. PMID: 28772226 Free article.

3

P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) limit brain accumulation of the FLT3 inhibitor quizartinib in mice.

Wang J, Gan C, Retmana IA, Sparidans RW, Li W, Lebre MC, Beijnen JH, Schinkel AH. Wang J, et al. Among authors: retmana ia. Int J Pharm. 2019 Feb 10;556:172-180. doi: 10.1016/j.ijpharm.2018.12.014. Epub 2018 Dec 12. Int J Pharm. 2019. PMID: 30553002

4

Quantification of KRAS inhibitor sotorasib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.

Retmana IA, Loos NHC, Schinkel AH, Beijnen JH, Sparidans RW. Retmana IA, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jun 1;1174:122718. doi: 10.1016/j.jchromb.2021.122718. Epub 2021 Apr 20. J Chromatogr B Analyt Technol Biomed Life Sci. 2021. PMID: 33957355 Free article.

5

ABCB1 limits brain exposure of the KRAS^G12C inhibitor sotorasib, whereas ABCB1, CYP3A, and possibly OATP1a/1b restrict its oral availability.

Loos NHC, Retmana IA, Li W, Martins MLF, Lebre MC, Sparidans RW, Beijnen JH, Schinkel AH. Loos NHC, et al. Among authors: retmana ia. Pharmacol Res. 2022 Apr;178:106137. doi: 10.1016/j.phrs.2022.106137. Epub 2022 Feb 19. Pharmacol Res. 2022. PMID: 35192958

6

Validated LC-MS/MS method for simultaneous quantification of KRAS^G12C inhibitor sotorasib and its major circulating metabolite (M24) in mouse matrices and its application in a mouse pharmacokinetic study.

Retmana IA, Loos NHC, Schinkel AH, Beijnen JH, Sparidans RW. Retmana IA, et al. J Pharm Biomed Anal. 2023 Oct 25;235:115612. doi: 10.1016/j.jpba.2023.115612. Epub 2023 Jul 31. J Pharm Biomed Anal. 2023. PMID: 37557065 Free article.

7

Pharmacokinetics of the KRAS^G12C inhibitor adagrasib is limited by CYP3A and ABCB1, and influenced by binding to mouse plasma carboxylesterase 1c.

Loos NHC, Retmana IA, Rijmers J, Wang Y, Gan C, Lebre MC, Sparidans RW, Beijnen JH, Schinkel AH. Loos NHC, et al. Among authors: retmana ia. Biomed Pharmacother. 2023 Oct;166:115304. doi: 10.1016/j.biopha.2023.115304. Epub 2023 Aug 14. Biomed Pharmacother. 2023. PMID: 37586117 Free article.

8

Development and validation of an HPLC-MS/MS method to quantify the KRAS inhibitor adagrasib in mouse plasma and tissue-related matrices.

Retmana IA, Loos NHC, Schinkel AH, Beijnen JH, Sparidans RW. Retmana IA, et al. Biomed Chromatogr. 2023 Nov;37(11):e5720. doi: 10.1002/bmc.5720. Epub 2023 Aug 19. Biomed Chromatogr. 2023. PMID: 37596864

9

Corrigendum to "Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines" [Vaccine 39(18) (2021) 2506-2516].

Stalpers CAL, Retmana IA, Pennings JLA, Vandebriel RJ, Hendriksen CFM, Akkermans AM, Hoefnagel MHN. Stalpers CAL, et al. Among authors: retmana ia. Vaccine. 2022 May 20;40(23):3272-3273. doi: 10.1016/j.vaccine.2022.04.047. Epub 2022 Apr 22. Vaccine. 2022. PMID: 35469695 Free article. No abstract available.

10

Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines.

Stalpers CAL, Retmana IA, Pennings JLA, Vandebriel RJ, Hendriksen CFM, Akkermans AM, Hoefnagel MHN. Stalpers CAL, et al. Among authors: retmana ia. Vaccine. 2021 Apr 28;39(18):2506-2516. doi: 10.1016/j.vaccine.2021.03.078. Epub 2021 Apr 3. Vaccine. 2021. PMID: 33824038 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page